Jayex Healthcare Limited (ASX:JHL) announced to the ASX that it has expanded into the Australian Allied Healthcare Professional (AHP) sector and has completed the acquisition of its counterpart in the UK.
Jayex Healthcare provides integrated healthcare services delivery platforms by incorporating its proprietary technologies, which comprise of patient workflow platforms called Enlighten and patient engagement platforms named Appointuit. The company also owns prescription delivery service platforms by the name Pharmacy Delivery 2 U and a remote pharmacy prescription processing and dispensing terminal called BluePoint. Jayex was listed on the ASX on 17 December 2015.
Jayex stated that it continues to focus on the commercialisation of its Enlighten platform, and develop the Appointuit patient solutions in the Australian market. Jayex has now integrated the two technologies and has commenced cross-selling of its products to its existing customers.
The company has received Expression of Interest from 534 Australian sites as at 31st December 2015, and the number of subscribers for its Appointuit software grew 9.3% in 6 months, from 2,096 to 2,291.
Jayex has launched trials for its Enlighten platform with major Australian medical centre operators such as Tri-Star, Ochre and Medical One which are scheduled to finish in early February. The company also stated that if these trials turn out to be successful, it will roll out the platforms in more than 100 sites.
The company completed the acquisition of Jayex UK and its Enlighten business on 18 December 2015. This acquisition process was commenced in 2013, when Jayex initially gained the license to operate the Enlighten patient workflow platform in Australia. This platform has been deployed across 1,900 clinics and 33 hospitals in the UK.
The UK subsidiary recently secured a £150,000 contract to supply and install digital signage across GP clinics in Sutherland City in the north East of England. It is currently in the process of completing a significant digital signage contact worth £2.1 million with the Port of Dover Authority.
JHL closed yesterday at $0.24 and has declined 18.6% since its recent listing on the ASX. It currently has a market capitalisation of $14.47 million.
Author: Simon Herrmann
Jan 15, 2016
Simon is a financial analyst at independent research firm Wise-owl who wants to change the world by disrupting the cliché approach to investment decision making with convergent thinking. Wise-owl’s goal is plain and simple: Find the best opportunities for our members by following a proven methodology and to create long-term value through high-quality advice, innovation, technology and education. We combine industry experience and the agile mentality of a start-up. Wise-owl is the future of stock market investing.